Netflix Raised U.K. Prices Again. History Says a Netflix Price Increase Has Never Cost It a Year of Revenue Growth.
Netflix raised prices on every U.K. plan in the past few days, taking the ad-supported standard tier from £5.99 to £7.99 a month.
Industry
If You'd Invested $1,000 in Bitcoin 10 Years Ago, Here's How Much You'd Have Today
A $1,000 investment in Bitcoin a decade ago would be worth more than $398,000 today.
Meet the Dirt Cheap 6.4%-Yielding Dividend Stock That's Beating the Market in 2026
Altria Group has outpaced the S&P 500 this year, with total returns of 24%, versus 14% for the major market index.
Chevron Stayed in Venezuela for 20 Years While Rivals Left. Here's Why Its CEO Says Patience Pays Off.
Its decision to remain after ExxonMobil and ConocoPhillips left has proven to be a major competitive advantage.
BWX Technologies Already Builds Reactors for the Navy. Why Is It Still the Cheapest Nuclear Stock?
It is the primary source of nuclear reactors and high-assay enriched fuel for the U.S. Navy's submarine and aircraft carrier fleet.
Retirees Face a Familiar Trap: Chase Yield or Chase Growth?
When deciding between yield and growth, it’s crucial to maintain focus on long-term goals.
Prediction: Micron Stock Will Skyrocket After Sept. 30
Micron (NASDAQ: MU) is set to report fourth-quarter earnings on Sept. 30, and it could be a huge day for the stock. Investors are going to be most curious about the health of the memory chip market and whether Micron ca…
Should You Buy Snowflake Stock After Its Recent Surge? The Answer Might Shock You.
Its stocks has rocketed 67% higher so far in 2026, but its sky-high valuation could limit further upside.
Social Security's Trump Bump-Led 2027 COLA Should Have Its First Silver Lining Since 2023, but There's a Steep Price to Pay for This Victory
Few announcements are more anticipated than the annual Social Security cost-of-living adjustment (COLA) reveal in October.
Despite Revenue Skyrocketing More Than 100%, Nvidia Stock Trades at 24 Times Forward Earnings. Is the Market Warning Investors About What's to Come?
During the most recent fiscal quarter, Nvidia's growth figures showed investors that the AI boom is still in full swing.
GitLab Is Starting to Prove the Bears Wrong
After turning in another solid quarter, GitLab (NASDAQ: GTLB) is starting to prove the bear case wrong, and its stock is finally beginning to reflect that, with its shares climbing on its latest report.
1 Unstoppable Cryptocurrency to Buy Before It Soars 270%
Bitcoin must grow at a nearly 40% annual rate to hit a price of $300,000 by 2030.
The S&P 500's Yield Is at Historic Lows. Here Are 3 Dividend Stocks I'd Buy in September.
McDonald's has raised its dividend for 49 straight years and currently offers a forward yield of 2.89%.
Grab COO Dumps 145,000 Company Shares After the Stock's 28% One-Year Decline
The transaction involved ~145,000 shares at an execution price of $3.48 per share, representing a total value of ~$506,000.
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85.
Prediction: SoundHound Passes $500 Million in Revenue Before It Turns a Profit
SoundHound grew second-quarter revenue 45% year over year to a record $61.9 million and now expects $230 million to $260 million for 2026.
Rocket Lab CFO Dumps Over 140,000 Company Shares Worth $8.8 Million Amid a 28% One-Year Return
The transaction involved ~140,000 shares with an estimated value of ~$8.8 million at a weighted average price of $62.63 per share on September 2, 2026.
FDA Approves Guardant360 CDx Companion Diagnostic For ESR1-Mutated Breast Cancer
(RTTNews) - Guardant Health Inc. (GH) announced that the U.S. Food and Drug Administration approved Guardant360 CDx as a companion diagnostic or CDx to identify patients with hormone receptor (HR)-positive, HER2-negativ…
This eVTOL Stock Could Set Early Investors Up for Life
Archer Aviation acquired three businesses from Boeing, one of which is developing autonomous eVTOLs.
Viking Therapeutics Trades Well Below Its Wall Street Targets. Here's the Skeptics' Case.
Viking Therapeutics has significant upside potential based on Wall Street targets.
Bill Gates Says He Still Won't Invest in Crypto, Calls It a "Pure Mania-Driven Asset." Here's Why He's Right.
Microsoft co-founder Bill Gates was recently asked where he would put money if he wanted to diversify away from the U.S. dollar. His choices included gold, the euro, Chinese yuan, and cryptocurrency. Gates said he still…
Resideo SVP Mehta Buys 10,928 Shares in $226,000 Direct Purchase
Amit Ashvin Mehta, SVP, Strategy & Business Ops of Resideo Technologies (NYSE:REZI), executed a direct purchase of 10,928 shares of common stock on Aug. 17, 2026, according to a recent SEC Form 4 filing.
IonQ vs. Rigetti Computing: Which Pure-Play Quantum Pioneer Has the Stronger Technology Advantage?
In the quantum computing investment sector, two popular stock picks are IonQ (NYSE: IONQ) and Rigetti Computing (NASDAQ: RGTI). Both of these quantum computing upstarts have a long way to go before becoming a viable inv…
CVB Financial Director Mike Maddox Buys 10,000 Shares
Director Mike Maddox purchased 10,000 shares of CVB Financial(NASDAQ:CVBF) at $22.03 per share on Aug. 31, 2026, according to a SEC Form 4 filing.